Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors
Plasminogen activator inhibitor-1 is known to play a paradoxical positive role in tumor angiogenesis, but its contribution to metastatic spread remains unclear. We studied the impact of plasminogen activator inhibitor (PAI)-1 deficiency in a transgenic mouse model of ocular tumors originating from r...
Saved in:
Published in: | Carcinogenesis (New York) Vol. 29; no. 11; pp. 2236 - 2242 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Journal Article Web Resource |
Language: | English |
Published: |
Oxford
Oxford University Press
01-11-2008
Oxford Publishing Limited (England) Irl Press at Oxford University Press |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Plasminogen activator inhibitor-1 is known to play a paradoxical positive role in tumor angiogenesis, but its contribution to metastatic spread remains unclear. We studied the impact of plasminogen activator inhibitor (PAI)-1 deficiency in a transgenic mouse model of ocular tumors originating from retinal epithelial cells and leading to brain metastasis (TRP-1/SV40 Tag mice). PAI-1 deficiency did not affect primary tumor growth or vascularization, but was associated with a smaller number of brain metastases. Brain metastases were found to be differentially distributed between the two genotypes. PAI-1-deficient mice displayed mostly secondary foci expanding from local optic nerve infiltration, whereas wild-type animals displayed more disseminated nodules in the scissura and meningeal spaces. SuperArray GEarray analyses aimed at detecting molecules potentially compensating for PAI-1 deficiency demonstrated an increase in fibroblast growth factor-1 (FGF-1) gene expression in primary tumors, which was confirmed by reverse transcription–polymerase chain reaction and western blotting. Our data provide the first evidence of a key role for PAI-1 in a spontaneous model of metastasis and suggest that angiogenic factors, such as FGF-1, may be important for primary tumor growth and may compensate for the absence of PAI-1. They identify PAI-1 and FGF-1 as important targets for combined antitumor strategies. |
---|---|
Bibliography: | ark:/67375/HXZ-MK2CK46B-2 istex:91D98768447B7E6C550C6CD42B9C537988E9FBC9 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 scopus-id:2-s2.0-56049102601 info:eu-repo/grantAgreement/EC/FP7/201279 |
ISSN: | 0143-3334 1460-2180 1460-2180 |
DOI: | 10.1093/carcin/bgn204 |